In a report released today, Matthew Borsch from BMO Capital maintained a Buy rating on Aveanna Healthcare Holdings (AVAH – Research Report), with a price target of $7.00. The company's shares closed last Wednesday at $3.77, close to its 52-week low of $3.72. According to TipRanks.com, Borsch is a 4-star analyst with an average return of 7.4% and a 62.5% success rate. Borsch covers the Healthcare sector, focusing on stocks such as Molina Healthcare, Encompass Health, and HCA Healthcare. Currently, the analyst consensus on Aveanna Healthcare Holdings is a Strong Buy with an average price target of $7.33, a 94.4% upside from current levels.
https://www.tipranks.com/news/blurbs/bmo-capital-thinks-aveanna-healthcare-holdings-stock-is-going-to-recover?utm_source=advfn.com&utm_medium=referral
Aveanna Healthcare (NASDAQ:AVAH)
Historical Stock Chart
From Jun 2022 to Jul 2022 Click Here for more Aveanna Healthcare Charts.
Aveanna Healthcare (NASDAQ:AVAH)
Historical Stock Chart
From Jul 2021 to Jul 2022 Click Here for more Aveanna Healthcare Charts.